About Andrew Gomperts
Form D filings for Hillhurst Biopharmaceuticals in 2023 list Andrew Gomperts as chief executive officer and director.
Andrew Gomperts first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Gomperts in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Gomperts works with at each company, as listed on that company's latest Form D.
Hillhurst Biopharmaceuticals, Inc. · Form D, Sep 26, 2023
JF
Jeff Friedman
Director
EG
Edward Gomperts
Executive officer and director